Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
Glioblastoma is the most common form of primary malignant brain tumor in adults and one of the most lethal human cancers, with high recurrence and therapy resistance. Glioblastoma cells display extensive genetic and cellular heterogeneity, which precludes a unique and common therapeutic approach. Th...
Saved in:
| Main Authors: | Laura Zarzuela, Raúl V. Durán, Mercedes Tomé |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance
by: Jianlin Pu, et al.
Published: (2025-05-01) -
Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance
by: Xing Li, et al.
Published: (2025-03-01) -
Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway
by: Xiaohang Cui, et al.
Published: (2025-07-01) -
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01) -
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment
by: Gilbert Aaron Lee, et al.
Published: (2025-03-01)